Medically reviewed by Jay N. Yepuri, MD Irritable bowel syndrome with constipation (IBS-C) affects everything from diet to ...

The following is a summary of “Improvement of irritable bowel syndrome with glucagon like peptide-1 receptor agonists: a ...

About Immuron Immuron Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and ...

The global irritable bowel syndrome treatment market size was valued at USD 3.48 billion in 2024 and is projected to reach ...

It is normal for two illnesses symptoms to overlap but if both have been correctly diagnosed choosing a course of therapy is ...

Dr Ray O’Connor takes a look at some of the most recent clinical studies on irritable bowel syndrome (IBS) ...

Probiotics, which refer to living microorganisms, are another possible treatment for IBS. They are similar to the microorganisms typically present in the digestive tract and may help treat IBS ...

Patients with irritable bowel syndrome are more likely to benefit from a diet that eliminates any food triggering an IgG ...

IBS is a functional gastrointestinal disorder ... bowel obstruction, and medication side effects. Healthcare providers may test for other conditions if you have symptoms such as: Blood and ...

Immuron will launch ProIBS® for the treatment of symptoms related to IBS in the retail pharmacy sales channel. Immuron has been a leader in digestive health in Australia for many years.